JPWO2020179781A1 - - Google Patents
Info
- Publication number
- JPWO2020179781A1 JPWO2020179781A1 JP2021504108A JP2021504108A JPWO2020179781A1 JP WO2020179781 A1 JPWO2020179781 A1 JP WO2020179781A1 JP 2021504108 A JP2021504108 A JP 2021504108A JP 2021504108 A JP2021504108 A JP 2021504108A JP WO2020179781 A1 JPWO2020179781 A1 JP WO2020179781A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019039349 | 2019-03-05 | ||
| JP2019039349 | 2019-03-05 | ||
| PCT/JP2020/008889 WO2020179781A1 (ja) | 2019-03-05 | 2020-03-03 | 五環式化合物の塩およびそれらの結晶 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020179781A1 true JPWO2020179781A1 (https=) | 2020-09-10 |
| JPWO2020179781A5 JPWO2020179781A5 (https=) | 2023-02-28 |
| JP7508441B2 JP7508441B2 (ja) | 2024-07-01 |
Family
ID=72337486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021504108A Active JP7508441B2 (ja) | 2019-03-05 | 2020-03-03 | 五環式化合物の塩およびそれらの結晶 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11420980B2 (https=) |
| EP (1) | EP3936189A4 (https=) |
| JP (1) | JP7508441B2 (https=) |
| KR (1) | KR102921161B1 (https=) |
| CN (1) | CN113646046B (https=) |
| AU (1) | AU2020233452B2 (https=) |
| BR (1) | BR112021015979A2 (https=) |
| CA (1) | CA3129764A1 (https=) |
| MX (1) | MX2021009774A (https=) |
| TW (2) | TWI870286B (https=) |
| WO (1) | WO2020179781A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020179780A1 (ja) | 2019-03-05 | 2020-09-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 五環式複素環化合物 |
| PT119624A (pt) * | 2024-07-29 | 2026-01-29 | Silva Escada Guilherme | Máquina modular para a dobragem de tubos de pvc |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5424896A (en) * | 1977-07-26 | 1979-02-24 | Bayer Ag | Benzodiazepineediones*preparation and use thereof |
| JPH09118621A (ja) * | 1995-06-20 | 1997-05-06 | Jie Iru Pharmaceut Co Ltd | 活性成分としてデヒドロエボジアミン−ＨＣｌを含有する記憶増強および抗痴呆剤 |
| WO2004033666A2 (en) * | 2002-10-11 | 2004-04-22 | Board Of Regents, The University Of Texas System | Method and compounds for inhibiting hec1 activity for the treatment of proliferative diseases |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD258234A1 (de) | 1987-03-05 | 1988-07-13 | Univ Leipzig | Verfahren zur herstellung von pyrido/3',2':4,5/thieno/2,3-e/imidazo-/1,2-c/pyrimidinen sowie strukturanaloger -pyrimido/1,2-c/pyrimidine bzw. -1,3-diazepino/1,2-c/pyrimidine |
| RU2117670C1 (ru) | 1988-10-31 | 1998-08-20 | Эйсай Ко., Лтд. | Производные триазоло[1,4]диазепина и способы их получения |
| TW197442B (https=) * | 1990-02-08 | 1993-01-01 | Pfizer | |
| US5621100A (en) * | 1992-07-24 | 1997-04-15 | Cephalon, Inc. | K-252a derivatives for treatment of neurological disorders |
| US5756494A (en) * | 1992-07-24 | 1998-05-26 | Cephalon, Inc. | Protein kinase inhibitors for treatment of neurological disorders |
| CL2004000348A1 (es) | 1997-04-15 | 2005-01-14 | Cephalon Inc & Kyowa Hakko Kog | Compuesto derivado de estaurosporina bis-n-sustituida, util para potenciar la funcion de neuronas colinergicas, estriadas, del prosencefalo basal y sensoriales. |
| CL2004000352A1 (es) | 1998-05-26 | 2005-05-27 | Cephalon Inc & Kyowa Hakko Kog | Uso de compuestos derivados de estaurosporina para potenciar la funcion de neuronas colinergicas, estriadas, de prosencefalo basal y sensoriales. |
| FR2779652B1 (fr) | 1998-06-15 | 2001-06-08 | Sod Conseils Rech Applic | Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique |
| AU2005299031B2 (en) | 2004-10-20 | 2011-11-10 | F. Hoffmann-La Roche Ag | Halogen substituted benzodiazepine derivatives |
| US9314318B2 (en) * | 2008-08-26 | 2016-04-19 | Zest Ip Holdings, Llc | Dental anchor apparatus and method |
| JP6557441B1 (ja) * | 2017-09-07 | 2019-08-07 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 五環式化合物 |
| WO2020179780A1 (ja) | 2019-03-05 | 2020-09-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 五環式複素環化合物 |
-
2020
- 2020-03-03 WO PCT/JP2020/008889 patent/WO2020179781A1/ja not_active Ceased
- 2020-03-03 EP EP20766851.8A patent/EP3936189A4/en active Pending
- 2020-03-03 TW TW113114065A patent/TWI870286B/zh active
- 2020-03-03 KR KR1020217025603A patent/KR102921161B1/ko active Active
- 2020-03-03 TW TW109106928A patent/TWI849070B/zh active
- 2020-03-03 BR BR112021015979-7A patent/BR112021015979A2/pt unknown
- 2020-03-03 AU AU2020233452A patent/AU2020233452B2/en active Active
- 2020-03-03 MX MX2021009774A patent/MX2021009774A/es unknown
- 2020-03-03 JP JP2021504108A patent/JP7508441B2/ja active Active
- 2020-03-03 CA CA3129764A patent/CA3129764A1/en active Pending
- 2020-03-03 CN CN202080014060.2A patent/CN113646046B/zh active Active
- 2020-09-15 US US17/021,544 patent/US11420980B2/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5424896A (en) * | 1977-07-26 | 1979-02-24 | Bayer Ag | Benzodiazepineediones*preparation and use thereof |
| JPH09118621A (ja) * | 1995-06-20 | 1997-05-06 | Jie Iru Pharmaceut Co Ltd | 活性成分としてデヒドロエボジアミン−ＨＣｌを含有する記憶増強および抗痴呆剤 |
| WO2004033666A2 (en) * | 2002-10-11 | 2004-04-22 | Board Of Regents, The University Of Texas System | Method and compounds for inhibiting hec1 activity for the treatment of proliferative diseases |
Non-Patent Citations (1)
| Title |
|---|
| HEMDAN, M. M. ET AL., CHEMICAL AND PHARMACEUTICAL BULLETIN, vol. 63, JPN6020017886, 2015, pages 450 - 456, ISSN: 0005275255 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3936189A1 (en) | 2022-01-12 |
| JP7508441B2 (ja) | 2024-07-01 |
| BR112021015979A2 (pt) | 2021-10-05 |
| KR20210135223A (ko) | 2021-11-12 |
| US11420980B2 (en) | 2022-08-23 |
| CN113646046A (zh) | 2021-11-12 |
| KR102921161B1 (ko) | 2026-02-02 |
| TWI849070B (zh) | 2024-07-21 |
| MX2021009774A (es) | 2021-09-08 |
| CN113646046B (zh) | 2024-05-17 |
| AU2020233452A1 (en) | 2021-09-02 |
| EP3936189A4 (en) | 2022-12-14 |
| TW202430531A (zh) | 2024-08-01 |
| WO2020179781A1 (ja) | 2020-09-10 |
| AU2020233452B2 (en) | 2025-04-10 |
| TW202100531A (zh) | 2021-01-01 |
| US20210024541A1 (en) | 2021-01-28 |
| TWI870286B (zh) | 2025-01-11 |
| CA3129764A1 (en) | 2020-09-10 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230217 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230217 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240305 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240507 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240528 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240619 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7508441 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |